drugset / Trial / NCT01986322
Immunogenicity and Safety of DTP/HB/Hib (Bio Farma)Compared to DTP/HB Given Simultaneously With Hib(Registered)Vaccine
RandomizedParallel-groupSingle-blindPrevention
Summary
The main objective of this study was to evaluate the protectivity and safety of DTP/HB/Hib (Bio Farma) vaccine compared to DTP/HB and Hib vaccine given simultaneously.
Timeline
- Start
- 2011-07
- Primary completion
- 2012-01
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | DTP/HB | Vaccine | 0.5 ml | Intramuscular |
| Subject | DTP/HB/Hib vaccine | Vaccine | 0.5 ml | Intramuscular |
| Comparator | Hib | Vaccine | 0.5 ml | Intramuscular |
Indications
No indication recorded.